Table_4.xls (5.5 kB)
Net Reclassification Improvement (NRI) and Clinical NRI for Various Endpoints for Baseline Troponin Assessed by Contemporary-Sensitivity, High-Sensitivity and Super-Sensitivity Assays in Addition to the Standard Framingham Risk Score.
dataset
posted on 2014-03-04, 03:07 authored by Johannes Tobias Neumann, Aki S. Havulinna, Tanja Zeller, Sebastian Appelbaum, Tarja Kunnas, Seppo Nikkari, Pekka Jousilahti, Stefan Blankenberg, Karsten Sydow, Veikko SalomaaNRI = net reclassification improvement, clinical NRI = NRI for individuals with an intermediate 10-year risk (5–20%) according to the Framingham Risk Score, MACE = major adverse cardiac events, CVD = cardiovascular disease, MI = myocardial infarction, HF = heart failure, cs-cTnI = troponin I measured by contemporary-sensitivity assay, hs-cTnI = troponin I measured by high-sensitivity assay, ss-cTnI = troponin I measured by super-sensitivity assay, ns = not significant.
History
Usage metrics
Categories
Keywords
cardiovascularAcute cardiovascular problemsHeart failureMyocardial infarctionstrokeClinical research designCross-sectional studiesDiagnostic medicinepathologyGeneral pathologybiomarkersepidemiologyBiomarker epidemiologyCardiovascular disease epidemiologyreclassificationnriendpointsbaselinetroponinhigh-sensitivitysuper-sensitivityassaysframingham
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC